Clinical Trial Update: GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation [Phase 2]

View source ↗

Summary

The Phase 2 feasibility study of the BARD Over-the-Wire Mesh Ablation System for paroxysmal atrial fibrillation has completed. The update reports the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• BARD Over-the-Wire Mesh Ablation System

Snippet

Sponsor: C. R. Bard | Conditions: Paroxysmal Atrial Fibrillation | Phase 2 | Status: COMPLETED